← Leaderboards
Lloyd P Aiello
Joslin Diabetes Center
$1,714,136
Attributed
$1,714,136
Total exposure
3
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $413.8K · FY2005–17$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,714,136 · 3
By mechanism
U10$1,063,193 · 1
R01$650,943 · 2
Top collaborators
No co-investigators on record.
Most similar at Joslin Diabetes Center
Same institution · by research overlap
- Edward P Feener$7,050,839
- Fabricio Simao$1,075,256
- Christian Rask-Madsen$1,402,866
Others in their field
Top investigators on “Diabetic Retinopathy”
- John M Lachin · George Washington University$140,240,809
- David M Nathan · Massachusetts Institute Of Technology$123,291,647
- Rose A Gubitosi-Klug · Case Western Reserve University$71,942,336
- Rohit Varma · University Of Southern California$56,244,772
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Adam R Glassman · Jaeb Center For Health Research, Inc.$50,075,374
Research focus
Diabetic RetinopathyEdemaClinical TrialsDrug Screening /EvaluationHuman Therapy EvaluationProtein Kinase CMedical ComplicationVitamin TherapyExperimental DesignsQuality Of LifeBlood LipidVitrectomyRetina DisorderCooperative StudyAntiinflammatory AgentsEnzyme InhibitorsTocopherolsClinical ResearchVascular Endothelial Growth FactorsCalpainBevacizumabBradykinin ReceptorDiabeticBradykinin
Grant awards (6)
Role of the kallikrein-kinin system in diabetic retinopathy$413,750
R01 · FY2017 · EY · contact PI
Diabetic Retinopathy Clinical Research Network$252,866
U10 · FY2005 · EY
Diabetic Retinopathy Clinical Research Network$291,010
U10 · FY2004 · EY
Diabetic Retinopathy Clinical Research Network$315,221
U10 · FY2003 · EY
Study Chair Core Center:DME Clinical Research Network$204,096
U10 · FY2002 · EY
SYSTEMIC VEGF AND DIABETIC RETINOPATHY--CLINICAL TRIALS$237,193
R01 · FY2000 · EY